US Patent Issued to Avertix Medical on Jan. 13 for "Advanced cardiovascular monitoring system with personalized ST-segment thresholds" (New Jersey, New York Inventors)

ALEXANDRIA, Va., Jan. 13 -- United States Patent no. 12,521,071, issued on Jan. 13, was assigned to Avertix Medical Inc. (Eatontown, N.J.).

"Advanced cardiovascular monitoring system with personalized ST-segment thresholds" was invented by David R. Fischell (Fair Haven, N.J.), Michael Sasha John (Long Branch, N.J.), David Keenan (Tinton Falls, N.J.), Steve Johnson (Rochester, N.Y.) and Gregg Turi (Hackettstown, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Systems and Methods are disclosed for detecting acute coronary syndrome (ACS) events, arrythmias, heart rate abnormalities, medication problems such as non-compliance or ineffective amount or type of medication, and demand/supply related cardiac isch...